• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Zealand Pharma A/S

+ Add to Watchlist

22Z:GR

9.437 EUR 0.066 0.70%

As of 02:12:36 ET on 09/17/2014.

Snapshot for Zealand Pharma A/S (22Z)

Open: 9.360 Day's Range: 9.350 - 9.437 Volume: 0
Previous Close: 9.371 52wk Range: 7.427 - 10.285 1-Yr Rtn: +11.55%

Stock Chart for 22Z

No chart data available.
  • 22Z:GR 9.350
  • 1D
  • 1M
  • 1Y
9.371
Interactive 22Z Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 22Z

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) -2.3720
Est. PEG Ratio -
Market Cap (M EUR) 218.87
Shares Outstanding (M) 23.19
30 Day Average Volume 19
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 22Z

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for 22Z

Zealand Pharma A/S is a biopharmaceutical company that discovers and develops peptide-based drugs.

David Horn SolomonPresident/CEOChristian GrondahlExec VP/Chief Scientific Officer
Mats BlomSenior VP/CFOAgneta SvedbergSenior VP/COO
More Company Profile & Key Executives for 22Z

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil